The molecular biology of HIV latency: breaking and restoring the Tat-dependent transcriptional circuit.
OBJECTIVE
Despite the remarkable success of intensive antiretroviral drug therapy in blocking the HIV replication, the virus persists in a small number of cells in which HIV has been transcriptionally silenced. This review will focus on recent insights into the HIV transcriptional control mechanisms that provide the biochemical basis for understanding latency.


RESULTS
Latency arises when the regulatory feedback mechanism driven by HIV Tat expression is disrupted. Small changes in transcriptional initiation, induced by epigenetic silencing, can lead to restrictions in Tat levels and entry of proviruses into latency. In resting memory T-cells, which carry the bulk of the latent viral pool, additional restrictions limiting cellular levels of the essential Tat cofactor P-TEFb and the transcription initiation factors nuclear factor kappa B and nuclear factor of activated T cells ensure that the provirus remains silenced unless the host cell is activated.


CONCLUSIONS
Strategies to purge the latent proviral pool require nontoxic activator molecules. The multiple restrictions imposed on latent proviruses that need to be overcome suggest that proviral reactivation will not be achieved when only a single reactivation step is targeted but will require both removal of epigenetic blocks and the activation of P-TEFb. Alternatively, new inhibitors that block proviral reactivation could be developed.
Department of Molecular Biology and Microbiology, Case Western Reserve University, Cleveland, Ohio, USA. jonathan.karn@case.edu
Jonathan
J
Karn
D006678:HIV / Q000235:genetics / Q000502:physiology*; D006801:Humans; D014158:Transcription, Genetic; D017735:Virus Latency; D054322:tat Gene Products, Human Immunodeficiency Virus / Q000037:antagonists & inhibitors* / Q000378:metabolism*
D054322:tat Gene Products, Human Immunodeficiency Virus
EMBO J. 2007 Jan 24;26(2):412-23
17245431
J Exp Med. 1998 Jun 15;187(12):2031-6
9625762
Science. 2001 Aug 31;293(5535):1653-7
11533489
J Virol. 2004 Feb;78(3):1160-8
14722271
EMBO J. 2006 Jan 11;25(1):139-49
16319923
J Virol. 1992 Sep;66(9):5594-7
1501293
Proc Natl Acad Sci U S A. 1998 Jul 21;95(15):8869-73
9671771
J Virol. 1998 Oct;72(10):8252-6
9733868
J Biol Chem. 2002 Jun 28;277(26):23733-41
11956207
EMBO J. 2009 May 20;28(10):1407-17
19387490
J Virol. 2009 Apr;83(7):3078-93
19144703
Cell. 1998 Nov 25;95(5):595-604
9845362
Virology. 2009 Jun 20;389(1-2):20-5
19447460
Science. 2010 Jul 9;329(5988):174-80
20616270
J Virol. 2007 Jun;81(11):6043-56
17376917
Cell. 1998 Feb 20;92(4):451-62
9491887
J Virol. 2010 Jul;84(13):6425-37
20410271
EMBO J. 2003 Dec 15;22(24):6550-61
14657027
PLoS Pathog. 2009 Jun;5(6):e1000495
19557157
Cell. 2005 Jul 29;122(2):169-82
16051143
Mol Cell. 2010 May 14;38(3):428-38
20471948
Cell Host Microbe. 2008 Aug 14;4(2):123-33
18692772
Retrovirology. 2009 Jun 02;6:52
19486542
J Virol. 2004 Jun;78(12):6122-33
15163705
PLoS Pathog. 2006 Jun;2(6):e60
16789841
J Biol Chem. 2006 Jul 21;281(29):19960-8
16687403
J Virol. 2009 Sep;83(17):8470-81
19535437
EMBO J. 2003 Apr 15;22(8):1868-77
12682019
Expert Rev Mol Med. 2009 Feb 11;11:e6
19208267
Nat Med. 2001 Apr;7(4):459-64
11283673
Mol Cell Biol. 2002 Feb;22(4):1079-93
11809800
J Virol. 2007 Jul;81(14):7424-34
17475639
Nat Med. 2000 Jan;6(1):82-5
10613829
Proc Natl Acad Sci U S A. 1994 Apr 26;91(9):3862-6
8171003
Nature. 2010 Jun 10;465(7299):747-51
20535204
EMBO J. 1993 Sep;12(9):3551-8
8253080
Nat Med. 2009 Aug;15(8):893-900
19543283
J Mol Biol. 2009 Oct 16;393(1):98-112
19683540
Nat Med. 2003 Jun;9(6):727-8
12754504
Mol Cell Biol. 2004 Jan;24(2):787-95
14701750
Genes Dev. 2008 May 15;22(10):1356-68
18483222
J Clin Invest. 2005 Nov;115(11):3250-5
16276421
Mol Cell Biol. 2002 Jul;22(13):4622-37
12052871
Nature. 1987 Apr 16-22;326(6114):711-3
3031512
Science. 1997 Nov 14;278(5341):1295-300
9360927
J Virol. 2009 Jun;83(12):6222-33
19369341
J Virol. 2010 Sep;84(17):8712-20
20538859
J Biol Chem. 1998 Sep 18;273(38):24898-905
9733796
Nature. 2001 Nov 15;414(6861):322-5
11713533
Blood. 2009 Jan 1;113(1):58-65
18849485
Proc Natl Acad Sci U S A. 1999 Dec 21;96(26):15109-14
10611346
Nat Genet. 2008 Apr;40(4):466-70
18344999
Proc Natl Acad Sci U S A. 2008 Oct 28;105(43):16725-30
18936487
Proc Natl Acad Sci U S A. 1998 Nov 10;95(23):13519-24
9811832
PLoS Pathog. 2009 Aug;5(8):e1000554
19696893
PLoS Pathog. 2009 Jan;5(1):e1000260
19132086
J Biol Chem. 2001 Apr 20;276(16):12951-8
11112772
J Biol Chem. 2010 May 28;285(22):16538-45
20335163
EMBO J. 1993 Aug;12(8):3249-59
8344262
Nature. 2001 Nov 15;414(6861):317-22
11713532
EMBO J. 2004 Jul 7;23(13):2608-19
15201869
Mol Cell Biol. 2000 May;20(9):2970-83
10757782
Immunity. 1997 Mar;6(3):235-44
9075924
Nature. 1999 Oct 28;401(6756):874-5
10553903
Proc Natl Acad Sci U S A. 2009 Jun 9;106(23):9403-8
19470482
J Virol. 2003 Apr;77(8):4938-49
12663799
EMBO J. 2007 Dec 12;26(24):4985-95
18007589
Science. 1986 May 9;232(4751):755-9
3008338
Proc Natl Acad Sci U S A. 2003 Oct 28;100(22):12955-60
14569007
J Clin Invest. 2009 Nov;119(11):3473-86
19805909
Mol Cell. 2010 May 14;38(3):439-51
20471949
J Biol Chem. 2007 Jun 8;282(23):16981-8
17442680
Mol Cell. 2003 Oct;12(4):971-82
14580347
EMBO J. 2007 Jan 24;26(2):424-35
17245432
Virology. 2009 Apr 25;387(1):98-108
19268337
J Virol. 2005 Jun;79(11):6610-9
15890899
Proc Natl Acad Sci U S A. 2010 Jan 5;107(1):46-51
20080798
J Virol. 1991 Aug;65(8):4350-8
2072454
J Mol Biol. 1995 May 5;248(3):562-80
7752225
Cell Host Microbe. 2008 Aug 14;4(2):134-46
18692773
J Virol. 2009 May;83(10):4749-56
19279091
Science. 2009 Mar 6;323(5919):1304-7
19265012
AIDS. 2009 Sep 10;23(14):1799-806
19590405
Nat Struct Biol. 2003 Oct;10(10):800-6
12949493
J Virol. 1997 Jul;71(7):5495-504
9188623
J Virol. 2008 Dec;82(24):12291-303
18829756